|
1
|
Vardiman JW: The World Health Organization
(WHO) classification of tumors of the hematopoietic and lymphoid
tissues: An overview with emphasis on the myeloid neoplasms. Chem
Biol Interact. 184:16–20. 2010. View Article : Google Scholar
|
|
2
|
Kęsy J and Januszkiewicz-Lewandowska D:
Genes and childhood leukemia. Postepy Hig Med Dosw (Online).
69:302–308. 2015. View Article : Google Scholar
|
|
3
|
Gao S, Bajrami I, Verrill C, Kigozi A,
Ouaret D, Aleksic T, Asher R, Han C, Allen P, Bailey D, et al: Dsh
homolog DVL3 mediates resistance to IGFIR inhibition by regulating
IGF-RAS signaling. Cancer Res. 74:5866–5877. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rokah OH, Granot G, Ovcharenko A, Modai S,
Pasmanik-Chor M, Toren A, Shomron N and Shpilberg O: Downregulation
of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
PLoS One. 7:e355012012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamaguchi H, Inokuchi K, Sakuma Y and Dan
K: Mutation of the p51/p63 gene is associated with blastic crisis
in chronic myelogenous leukemia. Leukemia. 15:1729–1734. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agirre X, Jiménez-Velasco A, San
José-Enériz E, Garate L, Bandrés E, Cordeu L, Aparicio O, Saez B,
Navarro G, Vilas-Zornoza A, et al: Down-regulation of hsa-miR-10a
in chronic myeloid leukemia CD34+ cells increases USF2-mediated
cell growth. Mol Cancer Res. 6:1830–1840. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miething C, Grundler R, Mugler C, Brero S,
Hoepfl J, Geigl J, Speicher MR, Ottmann O, Peschel C and Duyster J:
Retroviral insertional mutagenesis identifies RUNX genes involved
in chronic myeloid leukemia disease persistence under imatinib
treatment. Proc Natl Acad Sci USA. 104:4594–4599. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Y, Yang L, Zhao M, Zhu S, Kang R,
Vernon P, Tang D and Cao L: Targeting microRNA-30a-mediated
autophagy enhances imatinib activity against human chronic myeloid
leukemia cells. Leukemia. 26:1752–1760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hobert O: Gene regulation by transcription
factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Latchman DS: Transcription factors: An
overview. Int J Biochem Cell Biol. 29:1305–1312. 1997. View Article : Google Scholar
|
|
11
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The http://microRNA.orgurisimplemicroRNA.org resource:
Targets and expression. Nucleic Acids Res. 36(Database): D149–D153.
2008. View Article : Google Scholar
|
|
13
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky J: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papadopoulos GL, Reczko M, Simossis VA,
Sethupathy P and Hatzigeorgiou AG: The database of experimentally
supported targets: A functional update of TarBase. Nucleic Acids
Res. 37(Database): D155–D158. 2009. View Article : Google Scholar :
|
|
16
|
Hsu SD, Lin FM, Wu WY, Liang C, Huang WC,
Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al: miRTarBase: A
database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. 39(Database): D163–D169. 2011.
View Article : Google Scholar
|
|
17
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: An integrated resource for microRNA-target
interactions. Nucleic Acids Res. 37(Database): D105–D110. 2009.
View Article : Google Scholar
|
|
18
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14(10A): 1902–1910. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baskerville S and Bartel DP: Microarray
profiling of microRNAs reveals frequent coexpression with
neighboring miRs and host genes. RNA. 11:241–247. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia
W, Li J, Li S, Chen L, Ding H, et al: Intronic miR-301 feedback
regulates its host gene, ska2, in A549 cells by targeting MEOX2 to
affect ERK/CREB pathways. Biochem Biophy Res Commun. 396:978–982.
2010. View Article : Google Scholar
|
|
21
|
Vaidya S, Ghosh K, Shanmukhaiah C and
Vundinti BR: Genetic variations of hOCT1 gene and CYP3A4/A5 genes
and their association with imatinib response in Chronic Myeloid
Leukemia. Eur J Pharmacol. 765:124–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fallah P, Amirizadeh N, Poopak B, Toogeh
G, Arefian E, Kohram F, Hosseini Rad SM, Kohram M, Teimori Naghadeh
H and Soleimani M: Expression pattern of key microRNAs in patients
with newly diagnosed chronic myeloid leukemia in chronic phase. Int
J Lab Hematol. 37:560–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Lu M, Qiu C and Cui Q: TransmiR: A
transcription factor-microRNA regulation database. Nucleic Acids
Res. 38(Database): D119–D122. 2010. View Article : Google Scholar
|
|
24
|
Chekmenev DS, Haid C and Kel AE: P-Match:
transcription factor binding site search by combining patterns and
weight matrices. Nucleic Acids Res. 33(Web Server): W432–W437.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Flamant S, Ritchie W, Guilhot J, Holst J,
Bonnet ML, Chomel JC, Guilhot F, Turhan AG and Rasko JE: Micro-RNA
response to imatinib mesylate in patients with chronic myeloid
leukemia. Haematologica. 95:1325–1333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
27
|
Dong W, Zhang J, Shao N, Tian T, Li L,
Jian J, Zang S, Ma D and Ji C: Development and immunological
evaluation of HLA-specific chronic myeloid leukemia polyepitope
vaccine in Chinese population. Vaccine. 32:3501–3508. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sekiguchi Y, Shimada A, Matsuzawa M, Imai
H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Arita J,
Komatsu N and Noguchi M: Occurrence of carcinoma of the pancreas
following nilotinib therapy for chronic myeloid leukemia: Report of
a case with review of the literature. Turk J Haematol. 32:257–262.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Safran M, Dalah I, Alexander J, Rosen N,
Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T and Krug H:
GeneCards version 3: The human gene integrator. Database (Oxford).
baq0202010.
|
|
30
|
Fujita PA, Rhead B, Zweig AS, Hinrichs AS,
Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H and Coelho
A: The UCSC Genome Browser database: Update 2011. Nucleic Acids
Res. 39(Database): D876–D882. 2011. View Article : Google Scholar :
|
|
31
|
Matys V, Fricke E, Geffers R, Gössling E,
Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis
OV, et al: TRANSFAC: Transcriptional regulation, from patterns to
profiles. Nucleic Acids Res. 31:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Qiu C, Tu J, Geng B, Yang J, Jiang T
and Cui Q: HMDD v2.0: A database for experimentally supported human
microRNA and disease associations. Nucleic Acids Res. 42(D1):
D1070–D1074. 2014. View Article : Google Scholar :
|
|
33
|
Tzoanopoulos D, Speletas M, Arvanitidis K,
Veiopoulou C, Kyriaki S, Thyphronitis G, Sideras P, Kartalis G and
Ritis K: Low expression of interferon regulatory factor-1 and
identification of novel exons skipping in patients with chronic
myeloid leukaemia. Br J Haematol. 119:46–53. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao LJ, Wang YY, Li G, Ma LY, Xiong SM,
Weng XQ, Zhang WN, Wu B, Chen Z and Chen SJ: Functional features of
RUNX1 mutants in acute transformation of chronic myeloid leukemia
and their contribution to inducing murine full-blown leukemia.
Blood. 119:2873–2882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reuter S, Charlet J, Juncker T, Teiten MH,
Dicato M and Diederich M: Effect of curcumin on nuclear factor
kappaB signaling pathways in human chronic myelogenous K562
leukemia cells. Ann N Y Acad Sci. 1171:436–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye H, Liu X, Lv M, Wu Y, Kuang S, Gong J,
Yuan P, Zhong Z, Li Q, Jia H, et al: MicroRNA and transcription
factor co-regulatory network analysis reveals miR-19 inhibits CYLD
in T-cell acute lymphoblastic leukemia. Nucleic Acids Res.
40:5201–5214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nautiyal J, Du J, Yu Y, Kanwar SS, Levi E
and Majumdar AP: EGFR regulation of colon cancer stem-like cells
during aging and in response to the colonic carcinogen
dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol.
302:G655–G663. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nagel S, Venturini L, Przybylski GK,
Grabarczyk P, Schmidt CA, Meyer C, Drexler HG, Macleod RA and
Scherr M: Activation of miR-17–92 by NK-like homeodomain proteins
suppresses apoptosis via reduction of E2F1 in T-cell acute
lymphoblastic leukemia. Leuk Lymphoma. 50:101–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
